MACHINE LEARNING TECHNIQUES FOR AUTOMATIC EVALUATION OF CLINICAL TRIAL DATA

Patent №

US 11,526,953

Granted

2022-12-13

Filed 2019

Owner

IQVIA INC.

Lab

AI components

6

ml · nlp · vision · planning · evo · hardware

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

16451097

Aspects of the subject matter described in this specification are embodied in systems and methods that utilize machine-learning techniques to evaluate clinical trial data using one or more learning models trained to identify anomalies representing adverse events associated with a clinical trial investigation. In some implementations, investigation data collected at a clinical trial site is obtained. A set of models corresponding to the clinical trial site is selected. Each model included in the set of models is trained to identify, based on historical investigation data collected at the clinical trial site, a distinct set of one or more indicators that indicate a compliance risk associated with the investigation data. A score for the clinical trial site is determined based on the investigation data relative to the historical investigation data. The score represents a likelihood that the investigation data is associated with at least one indicator representing the compliance risk.

Machine learningNatural languageVisionPlanningEvolutionary computationAI hardwareG06Q 50/18G06N 3/09G06N 20/00G06N 20/20G16H 10/20G16H 10/60G16H 20/10G16H 50/20+3 more

AI classification

Machine learning1.00
Planning1.00
AI hardware1.00
Vision1.00
Natural language0.98
Evolutionary computation0.96
Knowledge representation0.41
Speech0.00

Ownership

IQVIA INC.

assignment · 495920570

Assignors

BONAGERI, VIRUPAXKUMAR, PATIL, RAJNEESH, THANGAVELU, NITHYANANDAN, HUANG, JIAN, A, VIJAY PRATAP

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC